Cargando…

Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary

Familial adenomatous polyposis (FAP) is a colorectal cancer predisposition syndrome with considerable genetic and phenotypic heterogeneity, defined by the development of multiple adenomas throughout the colorectum. FAP is caused either by monoallelic mutations in the adenomatous polyposis coli gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp, Janos, Kovacs, Marietta Eva, Matrai, Zoltan, Orosz, Enikő, Kásler, Miklós, Børresen-Dale, Anne-Lise, Olah, Edith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698287/
https://www.ncbi.nlm.nih.gov/pubmed/26446593
http://dx.doi.org/10.1007/s10689-015-9845-5
_version_ 1782408020477607936
author Papp, Janos
Kovacs, Marietta Eva
Matrai, Zoltan
Orosz, Enikő
Kásler, Miklós
Børresen-Dale, Anne-Lise
Olah, Edith
author_facet Papp, Janos
Kovacs, Marietta Eva
Matrai, Zoltan
Orosz, Enikő
Kásler, Miklós
Børresen-Dale, Anne-Lise
Olah, Edith
author_sort Papp, Janos
collection PubMed
description Familial adenomatous polyposis (FAP) is a colorectal cancer predisposition syndrome with considerable genetic and phenotypic heterogeneity, defined by the development of multiple adenomas throughout the colorectum. FAP is caused either by monoallelic mutations in the adenomatous polyposis coli gene APC, or by biallelic germline mutations of MUTYH, this latter usually presenting with milder phenotype. The aim of the present study was to characterize the genotype and phenotype of Hungarian FAP patients. Mutation screening of 87 unrelated probands from FAP families (21 of them presented as the attenuated variant of the disease, showing <100 polyps) was performed using DNA sequencing and multiplex ligation-dependent probe amplification. Twenty-four different pathogenic mutations in APC were identified in 65 patients (75 %), including nine cases (37.5 %) with large genomic alterations. Twelve of the point mutations were novel. In addition, APC-negative samples were also tested for MUTYH mutations and we were able to identify biallelic pathogenic mutations in 23 % of these cases (5/22). Correlations between the localization of APC mutations and the clinical manifestations of the disease were observed, cases with a mutation in the codon 1200–1400 region showing earlier age of disease onset (p < 0.003). There were only a few, but definitive dissimilarities between APC- and MUTYH-associated FAP in our cohort: the age at onset of polyposis was significantly delayed for biallelic MUTYH mutation carriers as compared to patients with an APC mutation. Our data represent the first comprehensive study delineating the mutation spectra of both APC and MUTYH in Hungarian FAP families, and underscore the overlap between the clinical characteristics of APC- and MUTYH-associated phenotypes, necessitating a more appropriate clinical characterization of FAP families.
format Online
Article
Text
id pubmed-4698287
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-46982872016-01-08 Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary Papp, Janos Kovacs, Marietta Eva Matrai, Zoltan Orosz, Enikő Kásler, Miklós Børresen-Dale, Anne-Lise Olah, Edith Fam Cancer Original Article Familial adenomatous polyposis (FAP) is a colorectal cancer predisposition syndrome with considerable genetic and phenotypic heterogeneity, defined by the development of multiple adenomas throughout the colorectum. FAP is caused either by monoallelic mutations in the adenomatous polyposis coli gene APC, or by biallelic germline mutations of MUTYH, this latter usually presenting with milder phenotype. The aim of the present study was to characterize the genotype and phenotype of Hungarian FAP patients. Mutation screening of 87 unrelated probands from FAP families (21 of them presented as the attenuated variant of the disease, showing <100 polyps) was performed using DNA sequencing and multiplex ligation-dependent probe amplification. Twenty-four different pathogenic mutations in APC were identified in 65 patients (75 %), including nine cases (37.5 %) with large genomic alterations. Twelve of the point mutations were novel. In addition, APC-negative samples were also tested for MUTYH mutations and we were able to identify biallelic pathogenic mutations in 23 % of these cases (5/22). Correlations between the localization of APC mutations and the clinical manifestations of the disease were observed, cases with a mutation in the codon 1200–1400 region showing earlier age of disease onset (p < 0.003). There were only a few, but definitive dissimilarities between APC- and MUTYH-associated FAP in our cohort: the age at onset of polyposis was significantly delayed for biallelic MUTYH mutation carriers as compared to patients with an APC mutation. Our data represent the first comprehensive study delineating the mutation spectra of both APC and MUTYH in Hungarian FAP families, and underscore the overlap between the clinical characteristics of APC- and MUTYH-associated phenotypes, necessitating a more appropriate clinical characterization of FAP families. Springer Netherlands 2015-10-07 2016 /pmc/articles/PMC4698287/ /pubmed/26446593 http://dx.doi.org/10.1007/s10689-015-9845-5 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Papp, Janos
Kovacs, Marietta Eva
Matrai, Zoltan
Orosz, Enikő
Kásler, Miklós
Børresen-Dale, Anne-Lise
Olah, Edith
Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary
title Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary
title_full Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary
title_fullStr Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary
title_full_unstemmed Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary
title_short Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary
title_sort contribution of apc and mutyh mutations to familial adenomatous polyposis susceptibility in hungary
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698287/
https://www.ncbi.nlm.nih.gov/pubmed/26446593
http://dx.doi.org/10.1007/s10689-015-9845-5
work_keys_str_mv AT pappjanos contributionofapcandmutyhmutationstofamilialadenomatouspolyposissusceptibilityinhungary
AT kovacsmariettaeva contributionofapcandmutyhmutationstofamilialadenomatouspolyposissusceptibilityinhungary
AT matraizoltan contributionofapcandmutyhmutationstofamilialadenomatouspolyposissusceptibilityinhungary
AT oroszeniko contributionofapcandmutyhmutationstofamilialadenomatouspolyposissusceptibilityinhungary
AT kaslermiklos contributionofapcandmutyhmutationstofamilialadenomatouspolyposissusceptibilityinhungary
AT børresendaleannelise contributionofapcandmutyhmutationstofamilialadenomatouspolyposissusceptibilityinhungary
AT olahedith contributionofapcandmutyhmutationstofamilialadenomatouspolyposissusceptibilityinhungary